Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strive Health is expanding its relationship with Nephrology Associates of Northern Illinois and Indiana to help manage up to 20,000 patients with kidney disease, according to a company press release.
Supernus Pharmaceuticals announced FDA approval of viloxazine extended-release capsules to treat ADHD in patients aged 18 years and older.The FDA has now given its consent to viloxazine (Qelbree, Supernus), a once-per-day oral nonstimulant for the treatment of ADHD, starting with children aged 6 years, as well as adolescents and adults, a company press release stated.
A novel catheter-based cardioneural ablation procedure reduced symptoms of vasovagal syncope by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.Early published reports of cardioneural ablation have shown promise for the relief of autonomically mediated bradycardia; however, cases are typically performed on a
Among patients hospitalized with COVID-19, dapagliflozin was well tolerated and did not increase risk of AKI in patients, according to data published in the Clinical Journal of the American Society of Nephrology.Further, dapagliflozin was well tolerated among patients with an eGFR below 60 mL/minute per 1.73² and among those with an eGFR above 60 mL/minute per 1.73².
An analysis of single-center data showed same-day discharge after atrial fibrillation ablation increased from 2020 to 2021, with reduction in total time spent in-hospital and no change in readmission rates for adverse events. Same-day discharge after AF ablation may be associated with improved patient satisfaction and reduced hospital resource utilization, Bruce A. Koplan, MD, MPH, FHRS, a